These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7176188)

  • 21. Prazosin-induced haemodynamic modification in human hypertension. Evidence from strain-gauge plethysmography. Part II.
    Romano S; Gizdulich P; Scarpelli PT
    Methods Find Exp Clin Pharmacol; 1981; 3(1):13-5. PubMed ID: 7230971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prazosin on hemodynamics and sympatho-adrenal activity in hypertensive patients.
    Eklund B; Hjemdahl P; Seideman P; Atterhög JH
    J Cardiovasc Pharmacol; 1983; 5(3):384-91. PubMed ID: 6191136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of a single dose of prazosin in 8 cases of mitral or aortic regurgitation].
    Juillard A; Batalla N; Leroy G; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1981 Oct; 74(10):1227-32. PubMed ID: 6796026
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immediate and long-term effects of prazosin on hemodynamics in chronic cardiac insufficiency].
    Champoud O; Brunhes G; Cribier A; Pasquis P; Letac B
    Arch Mal Coeur Vaiss; 1982 Jun; 75(6):687-93. PubMed ID: 6810798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circulatory homeostasis in patients with hypertension during acute and chronic blockade of alpha 1-adrenoreceptors].
    Nedogoda SV
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():539-42. PubMed ID: 2977517
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability in effect of low doses of prozosin in hypertensive Nigerians.
    Oviasu OV; Idahosa PE
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):757-62. PubMed ID: 827422
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative first dose effects of prazosin and tiodazosin (BL-5111) in spontaneously hypertensive rats.
    Roebel LE; Florczyk AP; Buyniski JP
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):29-35. PubMed ID: 441514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotensive action of prazosin.
    Huysmans FT; Thien T; Koene RA
    N Engl J Med; 1979 Jun; 300(23):1335-6. PubMed ID: 440342
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiologic mechanisms opposing the hemodynamic effects of prazosin.
    Izzo JL; Horwitz D; Keiser HR
    Clin Pharmacol Ther; 1981 Jan; 29(1):7-11. PubMed ID: 7460477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical pharmacology of prazosin in arterial hypertension with chronic renal insufficiency].
    Chaignon M; Le Roux E; Aubert P; Lucsko M; Flouvat B; Guédon J
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():71-7. PubMed ID: 6794530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of vasodilators.
    Lowenthal DT
    N Y State J Med; 1979 Jan; 79(1):66-9. PubMed ID: 282474
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enhanced alpha adrenoreceptor-mediated vasoconstrictor component in essential hypertension].
    Amann FW; Bolli P; Kiowski W; Bühler FR
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1941-4. PubMed ID: 7209472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
    Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.
    Rubin PC; Blaschke TF
    Br J Clin Pharmacol; 1980 Jul; 10(1):23-32. PubMed ID: 6994759
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuous blood pressure measurement in ambulatory patients in the assessment of prazosin regimens.
    Hunyor SN; Larkin H; Kenny P
    Med J Aust; 1980 Jul; 2(SP1):15-7. PubMed ID: 7421720
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
    Fitchett DH; Pathé M; Pardy R; Despas P
    Br Heart J; 1980 Aug; 44(2):215-20. PubMed ID: 7426176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.